The NIDDK in collaboration with the National Center for Complementary and Alternative Medicine (NCCAM) and the Office of Dietary Supplement (CDS) funded 11 clinical centers and a coordinating site for seven years from 2002 -2009 to investigate phytotherapy for benign prostatic hyperplasia (BPH). University of Colorado Denver (UCD) was selected as one of the 11 clinical centers for this study, known as the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) trial. The CAMUS study team designed a double-blind, placebo-controlled, eighteen-month clinical trial of treatment with single usual dose (320 mg/day), double usual dose (640 mg/day) and triple usual dose (960 mg/day) of saw palmetto (Serenoa repens) to determine the efficacy and safety of Serenoa repens at reducing the lower urinary tract symptoms associated with BPH. A total of 369 men, substantially more than the 350 specified in the protocol, have been randomized into the study and are currently being treated and followed at the 11 clinical centers. UCD randomized 30 men to either Serenoa repens or placebo. Of the 30 men who were randomized, 29 are in active treatment and follow-up. We anticipate that all will complete 18 months of follow-up as per protocol, however, the protocol-specified treatment period for the last participants randomized extends beyond the current funding period, which ends March 31, 2010. This proposal is for continued funding for the period July 1, 2010 to June 30, 2011 to allow the CAMUS clinical trial to complete its activities. Funding for this period is needed so that participants will have time to complete the full protocol-specified treatment period, and so that clinical centers can participate in data clean-up, final data analyses, and publication activities.

Public Health Relevance

This Study is being conducted because, despite worldwide use of phytotherapies, the effectiveness and side effects of these over-the-counter dietary supplements for men with benign prostatic hyperplasia are unclear. If Saw palmetto, one of the most commonly used supplements, is effective at reducing lower urinary tract symptoms, it might be preferred by many men because of its """"""""natural therapy"""""""" appeal, and its lower cost, relative to prescription medications for BPH.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
2U01DK063833-08
Application #
7991923
Study Section
Special Emphasis Panel (ZDK1-GRB-R (M2))
Program Officer
Kusek, John W
Project Start
2002-09-30
Project End
2011-06-30
Budget Start
2010-09-20
Budget End
2011-06-30
Support Year
8
Fiscal Year
2010
Total Cost
$77,349
Indirect Cost
Name
University of Colorado Denver
Department
Surgery
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Lee, Jeannette Y; Moore, Page; Kusek, John et al. (2014) Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto. J Altern Complement Med 20:48-52
Barry, Michael J; Cantor, Alan; Roehrborn, Claus G et al. (2013) Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms. J Urol 189:987-92
Andriole, Gerald L; McCullum-Hill, Christie; Sandhu, Gurdarshan S et al. (2013) The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial. J Urol 189:486-92
Helfand, Brian T; Lee, Jeanette Y; Sharp, Victoria et al. (2012) Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial. J Urol 188:2288-93
Barry, Michael J; Avins, Andrew L; Meleth, Sreelatha et al. (2011) Performance of the American Urological Association Symptom Index with and without an additional urge incontinence item. Urology 78:550-4
Barry, Michael J; Meleth, Sreelatha; Lee, Jeannette Y et al. (2011) Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA 306:1344-51
Helfand, Brian T; McVary, Kevin T; Meleth, Sreelatha et al. (2011) The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial. J Urol 185:2223-8
Lee, Jeannette Y; Foster Jr, Harris E; McVary, Kevin T et al. (2011) Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia. J Altern Complement Med 17:469-72
Lee, Jeannette; Andriole, Gerald; Avins, Andrew et al. (2009) Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. Clin Trials 6:628-36